Role of STK in mouse liver macrophage and endothelial cell responsiveness during acute endotoxemia

Journal of Leukocyte Biology

Volumn 88, Issue 2, 2010, Pages 373-382

  Laskin, Debra L ^a   Chen, Li ^a   Hankey, Pamela A ^b   Laskin, Jeffrey D ^c  

^a RUTGERS UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Endotoxin; Kupffer cells; Macrophage stimulating protein; Nitric oxide; TNF

Indexed keywords

CYCLOOXYGENASE 2; ICOSANOID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MEMBRANE RECEPTOR; MEMBRANE RECEPTOR TREM 3; MESSENGER RNA; PHOSPHOTRANSFERASE; PROSTAGLANDIN E SYNTHASE 1; SCATTER FACTOR; SCATTER FACTOR MSP; STEM CELL KINASE; TOLL LIKE RECEPTOR 4; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CD135 ANTIGEN; FLT3 PROTEIN, MOUSE; MYELENCEPHALON SPECIFIC SERINE PROTEASE; MYELENCEPHALON-SPECIFIC SERINE PROTEASE; SERINE PROTEINASE;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; ENZYME ACTIVITY; GENE EXPRESSION; KUPFFER CELL; LIVER CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; GENETICS; IMMUNOLOGY; INFLAMMATION; LIVER; LIVER DISEASE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ACUTE DISEASE; ANIMALS; ENDOTHELIAL CELLS; ENDOTOXEMIA; FMS-LIKE TYROSINE KINASE 3; INFLAMMATION; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MACROPHAGES; MICE; MICE, KNOCKOUT; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 77956419029     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0210113     Document Type: Article

References (61)

1. Bezerra, J. A., Witte, D. P., Aronow, B. J., Degen, S. J. (1993) Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. Hepatology 18, 394-399. (Pubitemid 23225112)
2. Degen, S. J., Stuart, L. A., Han, S., Jamison, C. S. (1991) Characterization of the mouse cDNA and gene coding for a hepatocyte growth factor-like protein: expression during development. Biochemistry 30, 9781-9791.
3. Wang, M. H., Gonias, S. L., Skeel, A., Wolf, B. B., Yoshimura, T., Leonard, E. J. (1994) Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-γ and epidermal growth factor-binding protein, members of the kallikrein family. J. Biol. Chem. 269, 13806-13810.
4. Wang, M. H., Skeel, A., Leonard, E. J. (1996) Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases. J. Clin. Invest. 97, 720-727.
5. Morrison, A. C., Wilson, C. B., Ray, M., Correll, P. H. (2004) Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-γ and lipopolysaccharide. J. Immunol. 172, 1825-1832. (Pubitemid 38116831)
6. Kawaguchi, M., Orikawa, H., Baba, T., Fukushima, T., Kataoka, H. (2009) Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein. FEBS J. 276, 3481-3490.
7. Bhatt, A. S., Welm, A., Farady, C. J., Vasquez, M., Wilson, K., Craik, C. S. (2007) Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proc. Natl. Acad. Sci. USA 104, 5771-5776.
8. Wang, M. H., Iwama, A., Skeel, A., Suda, T., Leonard, E. J. (1995) The murine STK gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. Proc. Natl. Acad. Sci. USA 92, 3933-3937.
9. Gaudino, G., Follenzi, A., Naldini, L., Collesi, C., Santoro, M., Gallo, K. A., Godowski, P. J., Comoglio, P. M. (1994) RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13, 3524-3532.
10. Okino, T., Egami, H., Ohmachi, H., Takai, E., Tamori, Y., Nakagawa, A., Nakano, S., Sakamoto, O., Suda, T., Ogawa, M. (2001) Immunohistochemical analysis of distribution of RON receptor tyrosine kinase in human digestive organs. Dig. Dis. Sci. 46, 424-429. (Pubitemid 32242694)
11. Iwama, A., Wang, M. H., Yamaguchi, N., Ohno, N., Okano, K., Sudo, T., Takeya, M., Gervais, F., Morissette, C., Leonard, E. J., Suda, T. (1995) Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood 86, 3394-3403.
12. Brunelleschi, S., Penengo, L., Lavagno, L., Santoro, C., Colangelo, D., Viano, I., Gaudino, G. (2001) Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin. Br. J. Pharmacol. 134, 1285-1295. (Pubitemid 33097259)
13. Nikolaidis, N. M. (2010) Ron receptor tyrosine kinase negatively regulates TNFα production in alveolar macrophages by inhibiting NF-κB activity and ADAM17 production. Shock 33, 197-204.
14. Nanney, L. B., Skeel, A., Luan, J., Polis, S., Richmond, A., Wang, M. H., Leonard, E. J. (1998) Proteolytic cleavage and activation of pro-macrophage-stimulating protein and upregulation of its receptor in tissue injury. J. Invest. Dermatol. 111, 573-581.
15. Leonard, E. J., Skeel, A. (1976) A serum protein that stimulates macrophage movement, chemotaxis and spreading. Exp. Cell Res. 102, 434-438.
16. Skeel, A., Yoshimura, T., Showalter, S. D., Tanaka, S., Appella, E., Leonard, E. J. (1991) Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity. J. Exp. Med. 173, 1227-1234.
17. Liu, Q. P., Fruit, K., Ward, J., Correll, P. H. (1999) Negative regulation of macrophage activation in response to IFN-γ and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J. Immunol. 163, 6606-6613.
18. Wang, M. H., Cox, G. W., Yoshimura, T., Sheffler, L. A., Skeel, A., Leonard, E. J. (1994) Macrophage-stimulating protein inhibits induction of nitric oxide production by endotoxin- or cytokine-stimulated mouse macrophages. J. Biol. Chem. 269, 14027-14031.
19. Wang, M. H., Zhou, Y. Q., Chen, Y. Q. (2002) Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand. J. Immunol. 56, 545-553. (Pubitemid 35454336)
20. Zhou, Y. Q., Chen, Y. Q., Fisher, J. H., Wang, M. H. (2002) Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J. Biol. Chem. 277, 38104-38110.
21. Chen, Y. Q., Fisher, J. H., Wang, M. H. (1998) Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J. Immunol. 161, 4950-4959.
22. Wilson, C. B., Ray, M., Lutz, M., Sharda, D., Xu, J., Hankey, P. A. (2008) The RON receptor tyrosine kinase regulates IFN-γ production and responses in innate immunity. J. Immunol. 181, 2303-2310.
23. Correll, P. H., Iwama, A., Tondat, S., Mayrhofer, G., Suda, T., Bernstein, A. (1997) Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct. 1, 69-83.
24. Muraoka, R. S., Sun, W. Y., Colbert, M. C., Waltz, S. E., Witte, D. P., Degen, J. L., Friezner Degen, S. J. (1999) The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. J. Clin. Invest. 103, 1277-1285.
25. Waltz, S. E., Eaton, L., Toney-Earley, K., Hess, K. A., Peace, B. E., Ihlendorf, J. R., Wang, M. H., Kaestner, K. H., Degen, S. J. (2001) Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J. Clin. Invest. 108, 567-576. (Pubitemid 32777736)
26. Knolle, P. A., Gerken, G. (2000) Local control of the immune response in the liver. Immunol. Rev. 174, 21-34.
27. Dhainaut, J. F., Marin, N., Mignon, A., Vinsonneau, C. (2001) Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit. Care Med. 29, S42-S47.
28. Lalor, P. F., Lai, W. K., Curbishley, S. M., Shetty, S., Adams, D. H. (2006) Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialized functions in vivo. World J. Gastroenterol. 12, 5429-5439.
29. Szabo, G., Romics Jr., L., Frendl, G. (2002) Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis. 6, 1045-1066. (Pubitemid 36026462)
30. Seki, S., Habu, Y., Kawamura, T., Takeda, K., Dobashi, H., Ohkawa, T., Hiraide, H. (2000) The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol. Rev. 174, 35-46. (Pubitemid 30201377)
31. Laskin, D. L., Gardner, C. R. (2007) Nonparenchymal cells, inflammatory macrophages and hepatoxocity. In Drug-Induced Liver Disease, 2nd ed. (N. Kaplowitz, L. D. DeLeve, eds.), New York, NY, USA, Informa Healthcare, 159-184.
32. Chen, L. C., Gordon, R. E., Laskin, J. D., Laskin, D. L. (2007) Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia. Exp. Mol. Pathol. 83, 311-326.
33. Chen, L. C., Laskin, J. D., Gordon, M. K., Laskin, D. L. (2008) Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp. Mol. Pathol. 84, 145-155.
34. Correll, P. H., Morrison, A. C., Lutz, M. A. (2004) Receptor tyrosine kinases and the regulation of macrophage activation. J. Leukoc. Biol. 75, 731-737.
35. McCloskey, T. W., Todaro, J. A., Laskin, D. L. (1992) Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology 16, 191-203.
36. Feder, L. S., Laskin, D. L. (1994) Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 β following acute endotoxemia. J. Leukoc. Biol. 55, 507-513.
37. Feder, L. S., Todaro, J. A., Laskin, D. L. (1993) Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J. Leukoc. Biol. 53, 126-132.
38. Laskin, D. L., Heck, D. E., Gardner, C. R., Feder, L. S., Laskin, J. D. (1994) Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin. J. Leukoc. Biol. 56, 751-758.
39. Koch, O. R., Pani, G., Borrello, S., Colavitti, R., Cravero, A., Farre, S., Galeotti, T. (2004) Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol. Aspects Med. 25, 191-198. (Pubitemid 38401941)
40. Morrison, A. C., Correll, P. H. (2002) Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J. Immunol. 168, 853-860.
41. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., Akira, S. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162, 3749-3752. (Pubitemid 29314747)
42. Ford, J. W., McVicar, D. W. (2009) TREM and TREM-like receptors in inflammation and disease. Curr. Opin. Immunol. 21, 38-46.
43. Colonna, M., Facchetti, F. (2003) TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J. Infect. Dis. 187 (Suppl. 2), S397-S401. (Pubitemid 36724514)
44. Kondomerkos, D. J., Kalamidas, S. A., Kotoulas, O. B. (2006) Effects of cyclic AMP-elevating hormones and autacoids on LPS-activated rat peritoneal, bronchoalveolar and hepatic (Kupffer) macrophages. Cell Biochem. Funct. 24, 245-256.
45. Wu, J. Z., Ogle, C. K., Ogle, J. D., Alexander, J. W. (1993) A comparison of hepatic, splenic, peritoneal and alveolar macrophages with respect to PGE2, TXB2, production and ADCC function. Prostaglandins Leukot. Essent. Fatty Acids 48, 149-153.
46. Valdivia, A., Perez-Alvarez, S., Aroca-Aguilar, J. D., Ikuta, I., Jordan, J. (2009) Superoxide dismutases: a physiopharmacological update. J. Physiol. Biochem. 65, 195-208.
47. Wang, M. H., Skeel, A., Yoshimura, T., Copeland, T. D., Sakaguchi, K., Leonard, E. J. (1993) Antibodies to macrophage stimulating protein (MSP): specificity, epitope interactions, and immunoassay of MSP in human serum. J. Leukoc. Biol. 54, 289-295. (Pubitemid 23317695)
48. Skeel, A., Leonard, E. J. (1994) Action and target cell specificity of human macrophage-stimulating protein (MSP). J. Immunol. 152, 4618-4623. (Pubitemid 24134422)
49. Mogensen, T. H. (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22, 240-273.
50. Balkwill, F. (2009) Tumor necrosis factor and cancer. Nat. Rev. Cancer 9, 361-371.
51. Marquis, J. F., Gros, P. (2008) Genetic analysis of resistance to infections in mice: A/J meets C57BL/6J. Curr. Top. Microbiol. Immunol. 321, 27-57.
52. Doetschman, T. (2009) Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol. Biol. 530, 423-433.
53. Gunella, G., Bardelli, C., Amoruso, A., Viano, I., Balbo, P., Brunelleschi, S. (2006) Macrophage-stimulating protein differently affects human alveolar macrophages from smoker and non-smoker patients: evaluation of respiratory burst, cytokine release and NF-κB pathway. Br. J. Pharmacol. 148, 478-489. (Pubitemid 43882084)
54. Laskin, D. L., Weinberger, B., Laskin, J. D. (2001) Functional heterogeneity in liver and lung macrophages. J. Leukoc. Biol. 70, 163-170.
55. Ivanov, A. I., Romanovsky, A. A. (2004) Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front. Biosci. 9, 1977-1993.
56. Hu, K. Q. (2003) Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases. Prostaglandins Leukot. Essent. Fatty Acids 69, 329-337.
57. 2 synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs) - a critical review. Curr. Med. Chem. 16, 4274-4296.
58. 2 synthases. Clin. Immunol. 119, 229-240.
59. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792.
60. Maderna, P., Godson, C. (2009) Lipoxins: resolutionary road. Br. J. Pharmacol. 158, 947-959.
61. Gardner, C. R., Gray, J. P., Joseph, L. B., Cervelli, J., Bremer, N., Kim, Y., Mishin, V., Laskin, J. D., Laskin, D. L. (2010) Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 243, 36-46.